Cost-Effectiveness of Maraviroc for Antiretroviral Treatment-Experienced HIV-infected Individuals in Mexico

Author： Contreras-Hernandez Iris Becker Debbie Chancellor Jeremy Kühne Felicitas Mould-Quevedo Joaquin Vega Gabriela Marfatia Shalaka

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.8, 2010-12, pp. : 903-914

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Efficacy Comparison among Three Antiretroviral Regimens in HIV-1 Infected, Treatment-Experienced Patients

By Ruof Jörg

Clinical Drug Investigation, Vol. 27, Iss. 7, 2007-01 ,pp. : 469-479

Adis International

Access to resources Recommend Favorite

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

By de Mendoza Carmen Morelló Judit Garcia-Gascó Pilar Rodríguez-Novoa Sonia Soriano Vincent

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 839-850

Informa Healthcare

Access to resources Recommend Favorite

Novel Antiretroviral Combinations in Treatment-Experienced Patients with HIV Infection: Rationale and Results

By Taiwo Babafemi Murphy Robert L. Katlama Christine

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1629-1642

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Antiretroviral Regimens for the Treatment of HIV/AIDS

By Anis A.H.

PharmacoEconomics, Vol. 18, Iss. 4, 2000-10 ,pp. : 393-404

Adis International

Access to resources Recommend Favorite

Fertility treatment options for HIV-infected individuals

By Sullivan-Pyke Chantae S Nurudeen Sahadat K Grossman Lisa C Sauer Mark V Douglas Nataki C

Future Virology, Vol. 8, Iss. 12, 2013-12 ,pp. : 1219-1231

Future Medicine

Access to resources Recommend Favorite